Hims & Hers’ 458% Rally Tested as FDA Undercuts Obesity Sales
The blistering rally in Hims & Hers Health Inc. that’s captivated meme-stock traders has ground to a halt, setting up a ...
Becker's Hospital Review21m
FDA sets deadline to end sales of Ozempic, Wegovy copycats
Semaglutide — the key ingredient in Ozempic and Wegovy — had been in shortage since 2022. Now that supply has stabilized, state-licensed compounding pharmacies and physicians must stop selling ...
Stocks go into reverse as Microsoft is said to cancel AI leases
U.S. stocksfell on Monday morning after media outlets, citing a TD Cowen (TD) report, said Microsoft (MSFT) has canceled some ...